| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 47.0949 | 37 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.4408 | 39 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.8513 | 40 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.7336 | 21 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.5454 | 47 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.2612 | 14 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 55.2646 | 60 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.0489 | 61 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.3642 | 34 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.8691 | 31 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.9401 | 27 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.5291 | 39 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 56.6894 | 62 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.6493 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 52.5907 | 55 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.7818 | 26 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.292 | 33 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.7131 | 35 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 48.5016 | 43 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.3294 | 55 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.6566 | 50 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.7468 | 59 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.7213 | 26 |